This study reports the first crystal structure for an antibody directed against an icosahedral virus, revealing structural details of the antigen-binding site.
Answers are grounded in this paper and cite their sources.
First anti-icosahedral virus antibody structure; extends structural immunology but leaves open therapeutic translation.
The crystal structure of the antigen-binding fragment of a monoclonal antibody (8F5) that neutralizes human rhinovirus serotype 2 has been determined by X-ray diffraction studies. Antibody 8F5, obtained by immunization with native HRV2 virions, cross-reacts with peptides of the viral capsid protein VP2, which contribute to the neutralizing immunogenic site B in this serotype. The structure was solved by the molecular replacement method and has been refined to an R-factor of 18.9% at 2.8 A resolution. The elbow angle, relating the variable and constant modules of the molecule is 127 degrees, representing the smallest elbow angle observed so far in an Fab fragment. Furthermore, the charged residues of the epitope can be well accommodated in the antigen-binding site. This is the first crystal structure reported for an antibody directed against an icosahedral virus.
No takes yet. Share an insight, caveat, or question.
Tormo et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: